ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

2-ヒドロキシ-1,2,3-プロパントリカルボン酸/リチウム,(1:x)

Lithium Citrate

HCID 13520
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
10377-38-5
標準SMILES
O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Li+].[Li+].[Li+]
InChIKey
WJSIUCDMWSDDCE-UHFFFAOYSA-K
分子式
C6H5Li3O7
平均分子量
210 g/mol
単同位体質量
210.0515378

概要

Lithium Citrate can cause developmental toxicity according to state or federal government labeling requirements.

名称と識別子

優先名称
Lithium Citrate
IUPAC
trilithium;2-hydroxypropane-1,2,3-tricarboxylate
現地名
2-ヒドロキシ-1,2,3-プロパントリカルボン酸/リチウム,(1:x)
英語名
citric acid, lithium salt
分子式
C6H5Li3O7
分子量
209.9227

名称と別名

Lithium citrateLitarexCITRIC ACID, TRILITHIUM SALTLithium Citrate (anhydrous)anhydrous lithium citrateCHEBI:64735Lithium (as citrate)CHEBI:64754NSC-758700Li-liquidRefChem:55514trilithium(1+) 2-hydroxypropane-1,2,3-tricarboxylate
名称をさらに表示
2-ヒドロキシ-1,2,3-プロパントリカルボン酸/リチウム,(1:x)Einecs 233-819-9citric acid, lithium salt2-Hydroxy-1,2,3-propanetricarboxylic acid/lithium,(1:x) salt
5Z6E9K79YVLithonate S919-16-4Trilithium citrateCitric acid trilithium saltLithium citrate anhydrousLithium (Citrate)1,2,3-Propanetricarboxylic acid, 2-hydroxy-, trilithium salt

データベース識別子

CAS
10377-38-5、313222-91-2、6080-58-6、919-16-4
PubChem CID
13520
DTXSID
DTXSID70883185
ChEMBL
CHEMBL1201170、CHEMBL2103738
ChEBI
CHEBI:64735
UNII
3655633623
EC Number
213-045-8、233-819-9、612-032-8、684-184-3
Nikkaji
J48.475J

物性

構造計算による物性

極性表面積
141 Ų
水素結合供与体数
1
水素結合受容体数
7
回転可能結合数
2
重原子数
16
形式電荷
0
複雑度
211

実験および物理化学的性質

Chemical ClassesMetals -> Organic Acids, Metal Salts
Human Drugs · 2 件

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physical DescriptionTetrahydrate: White deliquescent solid; [Merck Index]

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 6 件

Warning

H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]

P264+P265, P280, P305+P351+P338, and P337+P317 (click each P-code to see the statement)

Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory.

This chemical does not meet GHS hazard criteria for 96.4% (27 of 28) of all reports.

Not Classified

危険有害性情報

Regulatory Information · 4 件

Chemical: 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, trilithium salt

Hazard Traits - Developmental Toxicity

REACH registered substance: Lithium citrate (EC: 612-032-8)

Lithium citrate: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, trilithium salt: Human health tier I assessment
Hazards SummaryMay cause eye irritation; [GFS Chemicals MSDS] See Lithium.
Hazard Classes and Categories · 2 件

Not Classified

Eye Irrit. 2 (100%)

安全と保護具

Exposure Control and Personal Protection0.2 [mg/m3], inhalable fraction, as Li[German Research Foundation (DFG)]

毒性情報

Adverse EffectsNeurotoxin - Other CNS neurotoxin

安全データ

hs_code
2918150000

化学と産業

薬理情報

Pharmacodynamics · 1 件

Although lithium has been used for over 50 years in treatment of bipolar disorder, the mechanism of action is still unknown. Lithium's therapeutic action may be due to a number of effects, ranging from inhibition of enzymes such as glycogen synthase kinase 3, inositol phosphatases, or modulation of glutamate receptors.

Mechanism of Action · 1 件

The precise mechanism of action of Li+ as a mood-stabilizing agent is currently unknown. It is possible that Li+ produces its effects by interacting with the transport of monovalent or divalent cations in neurons. An increasing number of scientists have come to the conclusion that the excitatory neurotransmitter glutamate is the key factor in understanding how lithium works. Lithium has been shown to change the inward and outward currents of glutamate receptors (especially GluR3), without a shift in reversal potential. Lithium has been found to exert a dual effect on glutamate receptors, acting to keep the amount of glutamate active between cells at a stable, healthy level, neither too much nor too little. It is postulated that too much glutamate in the space between neurons causes mania, and too little, depression. Another mechanism by which lithium might help to regulate mood include the non-competitive inhibition of an enzyme called inositol monophosphatase. Alternately lithium's action may be enhanced through the deactivation of the GSK-3B enzyme. The regulation of GSK-3B by lithium may affect the circadian clock. GSK-3 is known for phosphorylating and thus inactivating glycogen synthase. GSK-3B has also been implicated in the control of cellular response to damaged DNA. GSK-3 normally phosphorylates beta catenin, which leads to beta catenin degratation. When GSK-3 is inhibited, beta catenin increases and transgenic mice with overexpression of beta catenin express similar behaviour to mice treated with lithium. These results suggest that increase of beta catenin may be a possible pathway for the therapeutic action of lithium.

FDA Pharmacological Classification · 2 件

LITHIUM CITRATE

Mood Stabilizer [EPC]

用途と製造

UsesUsed as an antidepressant; [Merck Index]
General Manufacturing Information1,2,3-Propanetricarboxylic acid, 2-hydroxy-, lithium salt (1:3): ACTIVE

関連反応

8 件
反応記録を作成
HRID 65823 の反応式
HRID 65823反応物として
HRID 723276 の反応式
HRID 723276反応物として
HRID 973242 の反応式
HRID 973242反応物として
HRID 1029329 の反応式
HRID 1029329生成物として
HRID 1155230 の反応式
HRID 1155230反応物として
HRID 1448432 の反応式
HRID 1448432反応物として
HRID 1716158 の反応式
HRID 1716158反応物として
HRID 2250300 の反応式
HRID 2250300反応物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート